https://www.glamclinicdubai.ae/en/cosmetic-injectables/mounjaro-injection/
In Dubai, access to Mounjaro (tirzepatide) is tightly regulated to ensure patient safety and ethical prescribing practices. The Dubai Health Authority (DHA) and the Ministry of Health and Prevention (MoHAP) enforce strict guidelines, leading to several categories of individuals being ineligible to receive a prescription for Mounjaro.
1. Individuals with Absolute Medical Contraindications
Certain medical conditions pose severe risks when taking Mounjaro and are considered absolute contraindications for prescribing the medication:
- Personal or Family History of Medullary Thyroid Carcinoma (MTC): Due to potential risks of thyroid C-cell tumors, including MTC, individuals with a personal or family history of MTC are not candidates for Mounjaro.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): Individuals with MEN 2, a genetic disorder linked to endocrine tumors like MTC, are excluded from Mounjaro use.
- Known Serious Hypersensitivity to Tirzepatide: If an individual has experienced severe allergic reactions to Mounjaro or its components, prescribing the medication is not recommended.
2. Individuals for Whom Mounjaro is Not Indicated or Studied
Mounjaro is specifically approved for certain medical conditions, and individuals not meeting these criteria are ineligible for a prescription:
- Individuals with Type 1 Diabetes: Mounjaro is not suitable for treating Type 1 Diabetes due to its mechanism of action.
- Individuals with a BMI below approved thresholds: Mounjaro is intended for clinical obesity or overweight with comorbidities, not for cosmetic weight loss.
- Children and Adolescents under 18: The safety and efficacy of Mounjaro in pediatric populations have not been established.
3. Individuals Requiring Extreme Caution
Certain groups may still be considered for Mounjaro but require careful monitoring due to potential risks:
- Pregnant or Planning Pregnancy: Mounjaro is generally not recommended during pregnancy.
- Breastfeeding Women: Caution is advised due to unknown effects on breastfed infants.
- Patients with a History of Pancreatitis: Special attention is needed due to potential associations with pancreatitis.
- Patients with Severe Gastrointestinal Disease: Conditions like severe gastroparesis may be exacerbated by Mounjaro.
- Patients with Severe Kidney or Liver Impairment: Close evaluation is necessary due to potential side effects on these organs.
- Patients on Medications with Significant Interactions: Mounjaro may interact with certain medications, requiring dosage adjustments.
- Patients with Diabetic Retinopathy: Monitoring is essential due to potential effects on eye health.
- Patients with Planned Surgery or Procedures: Considerations for anesthesia may affect Mounjaro use.
Overall, obtaining a prescription for Mounjaro in Dubai requires meeting strict medical criteria and adhering to regulatory standards. Failure to meet these criteria may result in ineligibility for Mounjaro prescription in the UAE.